A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
Han B, Kim BJ, Kim HS, Choi DR, Shim BY, Lee KH, Kim JW, Kim JH, Song H, Kim JH, Park CK, Lee JW, Kim MJ, Zang DY.
Han B, et al. Among authors: lee kh, lee jw.
J Cancer. 2021 Jan 1;12(3):912-917. doi: 10.7150/jca.50514. eCollection 2021.
J Cancer. 2021.
PMID: 33403047
Free PMC article.